Literature DB >> 25546002

Screening and surveillance for Barrett esophagus.

Paul Lochhead1, Andrew T Chan2.   

Abstract

Entities:  

Mesh:

Year:  2015        PMID: 25546002      PMCID: PMC4331337          DOI: 10.1001/jamainternmed.2014.6983

Source DB:  PubMed          Journal:  JAMA Intern Med        ISSN: 2168-6106            Impact factor:   21.873


× No keyword cloud information.
  10 in total

Review 1.  Is there publication bias in the reporting of cancer risk in Barrett's esophagus?

Authors:  N J Shaheen; M A Crosby; E M Bozymski; R S Sandler
Journal:  Gastroenterology       Date:  2000-08       Impact factor: 22.682

2.  The prevalence of Barrett's esophagus in the US: estimates from a simulation model confirmed by SEER data.

Authors:  T J Hayeck; C Y Kong; S J Spechler; G S Gazelle; C Hur
Journal:  Dis Esophagus       Date:  2010-03-26       Impact factor: 3.429

Review 3.  American Gastroenterological Association technical review on the management of Barrett's esophagus.

Authors:  Stuart J Spechler; Prateek Sharma; Rhonda F Souza; John M Inadomi; Nicholas J Shaheen
Journal:  Gastroenterology       Date:  2011-03       Impact factor: 22.682

4.  Medical professional liability claims related to esophageal cancer screening.

Authors:  Megan A Adams; Parul Divya Parikh; Kwon Miller; Joel H Rubenstein
Journal:  JAMA       Date:  2014-10-01       Impact factor: 56.272

5.  Surveillance of Barrett's esophagus and mortality from esophageal adenocarcinoma: a population-based cohort study.

Authors:  Romy E Verbeek; Max Leenders; Fiebo J W Ten Kate; Richard van Hillegersberg; Frank P Vleggaar; Jantine W P M van Baal; Martijn G H van Oijen; Peter D Siersema
Journal:  Am J Gastroenterol       Date:  2014-07-01       Impact factor: 10.864

6.  Cost-effectiveness of endoscopic surveillance of non-dysplastic Barrett's esophagus.

Authors:  Louisa G Gordon; George C Mayne; Nicholas G Hirst; Timothy Bright; David C Whiteman; David I Watson
Journal:  Gastrointest Endosc       Date:  2013-09-27       Impact factor: 9.427

7.  Incidence of adenocarcinoma among patients with Barrett's esophagus.

Authors:  Frederik Hvid-Jensen; Lars Pedersen; Asbjørn Mohr Drewes; Henrik Toft Sørensen; Peter Funch-Jensen
Journal:  N Engl J Med       Date:  2011-10-13       Impact factor: 91.245

8.  Health benefits and cost effectiveness of endoscopic and nonendoscopic cytosponge screening for Barrett's esophagus.

Authors:  Tatiana Benaglia; Linda D Sharples; Rebecca C Fitzgerald; Georgios Lyratzopoulos
Journal:  Gastroenterology       Date:  2012-10-03       Impact factor: 22.682

9.  Trends in esophageal adenocarcinoma incidence and mortality.

Authors:  Chin Hur; Melecia Miller; Chung Yin Kong; Emily C Dowling; Kevin J Nattinger; Michelle Dunn; Eric J Feuer
Journal:  Cancer       Date:  2012-12-11       Impact factor: 6.860

10.  Radiofrequency ablation vs endoscopic surveillance for patients with Barrett esophagus and low-grade dysplasia: a randomized clinical trial.

Authors:  K Nadine Phoa; Frederike G I van Vilsteren; Bas L A M Weusten; Raf Bisschops; Erik J Schoon; Krish Ragunath; Grant Fullarton; Massimiliano Di Pietro; Narayanasamy Ravi; Mike Visser; G Johan Offerhaus; Cees A Seldenrijk; Sybren L Meijer; Fiebo J W ten Kate; Jan G P Tijssen; Jacques J G H M Bergman
Journal:  JAMA       Date:  2014-03-26       Impact factor: 56.272

  10 in total
  3 in total

Review 1.  Systematic Analysis and Critical Appraisal of the Quality of the Scientific Evidence and Conflicts of Interest in Practice Guidelines (2005-2013) for Barrett's Esophagus.

Authors:  Joseph D Feuerstein; Natalia E Castillo; Mona Akbari; Edward Belkin; Jeffrey J Lewandowski; Christine M Hurley; Samuel Lloyd; Daniel A Leffler; Adam S Cheifetz
Journal:  Dig Dis Sci       Date:  2016-06-15       Impact factor: 3.199

2.  Nanofiber capsules for minimally invasive sampling of biological specimens from gastrointestinal tract.

Authors:  Johnson V John; Alec McCarthy; Yajuan Su; Daniel N Ackerman; S M Shatil Shahriar; Mark A Carlson; St Patrick Reid; Joshua L Santarpia; Wuqiang Zhu; Jingwei Xie
Journal:  Acta Biomater       Date:  2022-05-02       Impact factor: 10.633

3.  Methylation panel is a diagnostic biomarker for Barrett's oesophagus in endoscopic biopsies and non-endoscopic cytology specimens.

Authors:  Hamza Chettouh; Oliver Mowforth; Núria Galeano-Dalmau; Navya Bezawada; Caryn Ross-Innes; Shona MacRae; Irene Debiram-Beecham; Maria O'Donovan; Rebecca C Fitzgerald
Journal:  Gut       Date:  2017-10-30       Impact factor: 23.059

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.